Results 121 to 130 of about 9,967 (136)
Some of the next articles are maybe not open access.
Cancer Research
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma with a poor patient overall survival rate. While Bruton tyrosine kinase inhibitors (BTKis) have shown benefit in relapsed/refractory MCL (Wang M, et al., 2018; Song Y, et al.,2020; Wang ML et al., 2013) a portion of patients eventually progress.
Anuvrat Sircar +11 more
openaire +1 more source
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma with a poor patient overall survival rate. While Bruton tyrosine kinase inhibitors (BTKis) have shown benefit in relapsed/refractory MCL (Wang M, et al., 2018; Song Y, et al.,2020; Wang ML et al., 2013) a portion of patients eventually progress.
Anuvrat Sircar +11 more
openaire +1 more source
The importance of tyrosine kinase-like orphan receptor 1 (Ror-1) in chronic lymphocytic leukemia
2021© 2021, UHOD - Uluslararasi Hematoloji Onkoloji Dergisi. All rights reserved.Type 1 tyrosine kinase–like orphan receptor (ROR-1) is expressed on neoplastic B cell surface in chronic lymphocytic leukemia (CLL). In this study, we aimed to determine the prognostic significance of ROR-1 expression with relationship of clinical features and therapy ...
Ozturk, Hacer Berna Afacan +6 more
openaire +1 more source
The role of the receptor tyrosine kinase-like orphan receptors (RORs) in human breast cancer
2022openaire +1 more source
An Orphan Receptor Tyrosine Kinase Family Whose Members Serve as Nonintegrin Collagen Receptors
Molecular Cell, 1997Czeslaw Radziejewski +2 more
exaly
The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells
Molecular Endocrinology, 2005Julia Billiard, Peter V N Bodine
exaly